Guinea-Bissau vs Serbia: Contraceptive prevalence, any modern method
Contraceptive prevalence, any modern method over time
- Guinea-Bissau
- Serbia
How they compare
Serbia currently reports 21.3% against 20.2% in Guinea-Bissau, a difference of 1.1%.
That makes Serbia's figure about 1.1 times Guinea-Bissau's.
Across all 5 years both countries report, Serbia has been ahead every year.
Guinea-Bissau ranks 97th and Serbia ranks 95th of 113 countries.
Serbia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.0% | 26.0% | 19.0% | Serbia |
| 2010s | 15.9% | 20.7% | 4.8% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher contraceptive prevalence, any modern method, Guinea-Bissau or Serbia?
- Serbia, at 21.3% against 20.2% in Guinea-Bissau as of 2019.
- What is the difference in contraceptive prevalence, any modern method between Guinea-Bissau and Serbia?
- 1.1%, with Serbia ahead.
- How many years of comparable data are there for Guinea-Bissau and Serbia?
- 5 years are reported by both, from 2000 to 2019.
- How do Guinea-Bissau and Serbia rank globally for contraceptive prevalence, any modern method?
- Guinea-Bissau ranks 97th and Serbia ranks 95th of 113 countries.
- Where does this data come from?
- Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.